This study proposes that the calcium signaling pathway is the primary signaling pathway targeted by WK in arrhythmia treatment because of the WK targets, including CaMKII, CNCA1C, and Ca2+, involved in the calcium signaling pathway. This evidence concerns the gene CAMK2G and cardiac arrhythmia.